CJ Bioscience announced on the 9th that it has decided to raise 40 billion KRW through a third-party allotment paid-in capital increase to secure operating funds. A total of 3,952,960 new common shares will be issued at 10,119 KRW per share. The third-party allotment recipient is the largest shareholder, CJ CheilJedang (3,952,960 shares).



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing